|
 |
| home > pmps > summer 2002 > new manufacturing technologies - from drug discovery to final product |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Anyone working within the life sciences industries knows that it takes significant investments of time, human and monetary resources to bring a new drug from discovery to the finished goods state. During the last decade, average times for this process peaked at 15 years from inception to launch. During that time, all pharmaceutical firms worked aggressively to reduce the time to develop and market, and the late 1990s saw dramatic reductions (some as much as 40 per cent, but on average, reductions took the process from 15 years to around nine to 10 years).
The industry was once quite unique in its record of business success. With high growth rates, barriers to entry and profits, the pharmaceutical industry was recognised as one of the most successful business spaces in the world marketplace. Recent years, however, have seen the industry running up against a number of unforeseen changes in the manufacturing life cycle.
These changes have inhibited the development, marketing and eventual sales of new drugs, and have increased potential risks and the costs associated with them. Similar changes have taken place across the breadth of life sciences manufacturing, extending beyond pharmaceuticals to nutraceuticals/ dietary supplements, to clinical and biotech manufacturing, resulting in heightened risk, threats to agility, challenges in enterprise-wide collaboration, and impaired time to market.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Benjamin Bryant, Global Communications, at Honeywell Industry Solutions for Chemicals, Life Sciences and Consumer Goods Benjamin Bryant co-ordinates global communications for Honeywell's Chemicals, Life Sciences, and Consumer Goods business, his employer since 2000, when he represented the POMS business exclusively. Prior appointments include service as well-known radio and news presenter in Austin, Texas, and work for the United States Army & Exchange Service in merchandising and promotions.
Benjamin is a member of the Association of the United States Army and the Public Relations Society of America, where he serves on the 12-member executive board of the society's international section. He has attended the University of Texas and the business programme at the University of Phoenix.
|
|
|
|
|
|
 |
Industry Events |
 |
7th Annual Pharma Packaging and Labelling conference
17 September - 18 October 2008, Barcelona
7th Annual Pharma Packaging and Labelling conference will bring
together experts from leading pharma manufacturers to present case study driven
presentations on critical industry-wide issues.
Attending this event will give you an opportunity to discuss with fellow
packaging and labelling professionals and share your views on these important
matters.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
